rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-9-25
|
pubmed:databankReference |
|
pubmed:abstractText |
To determine with electronic monitoring an objective measurement of adherence in two populations of subjects: those using once-daily prostaglandin analogs as sole ocular hypotensive therapy (one-drug group) and those requiring an adjunctive medicine to the prostaglandin analog (two-drug group).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0002-9394
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
144
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
533-40
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17686450-Adult,
pubmed-meshheading:17686450-Aged,
pubmed-meshheading:17686450-Aged, 80 and over,
pubmed-meshheading:17686450-Antihypertensive Agents,
pubmed-meshheading:17686450-Drug Monitoring,
pubmed-meshheading:17686450-Drug Prescriptions,
pubmed-meshheading:17686450-Drug Therapy, Combination,
pubmed-meshheading:17686450-Drug Utilization,
pubmed-meshheading:17686450-Female,
pubmed-meshheading:17686450-Glaucoma, Open-Angle,
pubmed-meshheading:17686450-Humans,
pubmed-meshheading:17686450-Intraocular Pressure,
pubmed-meshheading:17686450-Male,
pubmed-meshheading:17686450-Middle Aged,
pubmed-meshheading:17686450-Ocular Hypertension,
pubmed-meshheading:17686450-Ophthalmic Solutions,
pubmed-meshheading:17686450-Patient Compliance,
pubmed-meshheading:17686450-Time Factors
|
pubmed:year |
2007
|
pubmed:articleTitle |
Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use.
|
pubmed:affiliation |
Wilmer Institute, Johns Hopkins University, Baltimore, Maryland, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|